# Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

> **NCT06485505** · PHASE1 · RECRUITING · sponsor: **Zagazig University** · enrollment: 36 (estimated)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** ISOtretinoin 10 MG
- **DEVICE:** excimer light
- **DRUG:** Itraconazole 200 mg

## Key facts

- **NCT ID:** NCT06485505
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-12
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06485505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06485505, "Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06485505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*